Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Score on the Observational Scale of Behavioral Distress Revised (OSBD-R)
研究概览
简要总结
Children can develop abscesses (a collection of pus under their skin) that require a physician to cut it open to let the pus drain out. This is a painful procedure. Most medical professionals will use numbing cream and inject numbing medicine into the skin, just like at the dentist, to help reduce the pain. While this helps minimize the pain of cutting the skin, it doesn't help the pain associated with draining out the pus.
There are many strategies and medications available to physicians to help decrease the pain of this procedure. Most of the medications available to treat the pain require the placement of an intravenous (IV) catheter through the patient's skin, which itself is a painful procedure. In the investigators emergency department, many patients with abscesses that need a procedure to drain the pus receive a medicine called morphine through an IV.
Some pain medicines, however, can be sprayed into a patient's nose, and have been shown to be helpful at reducing the pain of a broken bone or a burn. These medicines do not require the placement of an IV.
The purpose of this research study is to determine whether a medicine called fentanyl, when sprayed into the nose of patients aged 4 to 18 years undergoing abscess drainage, is not worse than IV morphine in decreasing the pain of the procedure.
After the risks and benefits of the study are explained to patients and their parents, written informed consent will be obtained. Written informed assent will be obtained for patients older than 8 years of age. Like the flipping of a coin, a computer program will decide randomly which half of the patients will receive fentanyl nose spray and which half will receive morphine by IV.
The patients assigned to receive fentanyl nose spray will not have an IV placed. The patients assigned to receive morphine will have an IV placed. Both groups of patients will have the abscess drainage procedure done the same way. All patients will be videotaped in order to score their pain by a trained observer. This score is the main outcome (measurement) in the study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 4 Years 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient is 4 years of age up to their 18th birthday
- •Patient has a cutaneous abscess for which an I&D is to be performed
排除标准
- •Patient's parent doesn't speak English or Spanish
- •Patient has developmental delay or neurological impairment
- •Patient has altered mental status
- •Known hypersensitivity to study drugs (fentanyl, morphine sulfate, lidocaine, LMX4®)
- •The presence of significant blood or mucous in the nares despite blowing nose or suctioning
- •Severe renal or liver dysfunction, signs of respiratory distress or depression, any respiratory distress, chronic and severe asthma, upper airway obstruction, suspected gastrointestinal obstruction, suspected paralytic ileus
- •Narcotic analgesia within 4 hours of ED physician evaluation
- •Need for moderate sedation, deep sedation, or general anesthesia
- •Need for subspecialty consultation to perform the I&D
- •Need for I&D of more than 1 skin abscess
- •Cutaneous abscesses located on the genitals, breasts, face, or neck
- •Previous enrollment in the study
- •Patients with chronic pain syndromes (sickle cell disease, cancer, arthritis, inflammatory bowel disease)
研究组 & 干预措施
Intranasal Fentanyl
Patients in this arm will receive intranasal Fentanyl (50 micrograms/mL) as their pre-I&D analgesic. The one time total dose to be used is 2 micrograms / kilogram, to a maximum of 100 micrograms. The medication will be delivered intranasally via an atomizer in 4 equally divided aliquots (2 per nare).
The abscess I&D will be followed according to protocol using topical and local anesthetic.
干预措施: Intranasal Fentanyl (Drug)
Intravenous Morphine
Patients in this arm will receive intravenous morphine as their pre-I&D analgesic. The one time total dose to be used is 0.1 milligrams / kilogram, to a maximum of 8 milligrams. The medication will be delivered via slow IV push.
The abscess I&D will be followed according to protocol using topical and local anesthetic.
干预措施: Intravenous Morphine (Drug)
结局指标
主要结局
Score on the Observational Scale of Behavioral Distress Revised (OSBD-R)
时间窗: Up to 10 minutes after the procedure completion
Our primary outcome is the Observational Scale of Behavioral Distress - Revised (OSBD-R) to assess observed intra-procedural pain. The total OSBD-R score is a summation of the OSBD-R score of each individual phase. The score in each phase can range from 0 to 23.5. There were four phases in our study, so the range of scores for the total OSBD-R was 0 to 94, with a higher score indicating a greater degree of pain and distress. The four phases in the study are (1) before analgesia administration, (2) ten minutes after analgesia administration but before beginning I\&D, (3) immediately post I\&D procedure (to ascertain the pain perceived during procedure), and (4) ten minutes after procedure completion. The scores documented here are the total OSBD-R scores.
次要结局
- Score on the Faces Pain Scale Revised (FPS-R)(Up to 10 minutes after procedure completion)
- Number of Patients Satisfied With Analgesia Administered(10 minutes after procedure completion)
研究者
Daniel S Tsze, MD, MPH
Assistant Professor of Clinical Pediatrics
Columbia University